← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Antagen Pharmaceuticals, Inc.
Boston, MA
$2,549,909
Total funding
6
Grants
Funding over time
peak $600K · FY2011–22$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,549,909 · 6
By mechanism
N43$1,949,912 · 5
N01$599,997 · 1
Investigators at Antagen Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
SBIR TOPIC 081: ADJUVANT DEVELOPMENT FOR VACCINES AGAINST INFECTIOUS OR IMMUNE-MEDIATED DISEASES$600,000
N43 · FY2020 · AI
New CHO Cell Line and Approach to Produce Stabilized HIV Envelope Antigen for Vaccination$599,997
N01 · FY2018 · AI
Nanoparticle Delivery of HIV Env Trimer for Inducing Somatic Hypermutation and bNAb$599,914
N43 · FY2019 · AI
Development of Monoclonal Antibody-mediated Interventions to Combat Malaria$300,000
N43 · FY2022 · AI
FcRider-based Expression and Delivery of Stable Env Immunogens for HIV Vaccines$299,998
N43 · FY2022 · AI
TAS::75 0893::TAS RAPID LARGE SCALE PRODUCTION OF PROTEIN THERAPEUTICS$150,000
N43 · FY2011 · DA